BPG is committed to discovery and dissemination of knowledge
Featured Articles
9/29/2024 12:20:05 PM | Browse: 66 | Download: 47
|
Received |
|
2024-05-17 11:05 |
|
Peer-Review Started |
|
2024-05-17 11:05 |
|
To Make the First Decision |
|
|
|
Return for Revision |
|
2024-08-21 23:35 |
|
Revised |
|
2024-08-23 10:46 |
|
Second Decision |
|
2024-09-06 03:03 |
|
Accepted by Journal Editor-in-Chief |
|
|
|
Accepted by Executive Editor-in-Chief |
|
2024-09-06 06:13 |
|
Articles in Press |
|
2024-09-06 06:13 |
|
Publication Fee Transferred |
|
|
|
Edit the Manuscript by Language Editor |
|
2024-09-14 22:54 |
|
Typeset the Manuscript |
|
2024-09-19 07:44 |
|
Publish the Manuscript Online |
|
2024-09-29 09:24 |
ISSN |
1007-9327 (print) and 2219-2840 (online) |
Open Access |
This article is an open-access article that was selected by an in-house editor and fully peer-reviewed by external reviewers. It is distributed in accordance with the Creative Commons Attribution NonCommercial (CC BY-NC 4.0) license, which permits others to distribute, remix, adapt, build upon this work non-commercially, and license their derivative works on different terms, provided the original work is properly cited and the use is non-commercial. See: http://creativecommons.org/Licenses/by-nc/4.0/ |
Copyright |
© The Author(s) 2024. Published by Baishideng Publishing Group Inc. All rights reserved. |
Article Reprints |
For details, please visit: http://www.wjgnet.com/bpg/gerinfo/247
|
Permissions |
For details, please visit: http://www.wjgnet.com/bpg/gerinfo/207
|
Publisher |
Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA |
Website |
http://www.wjgnet.com |
Category |
Gastroenterology & Hepatology |
Manuscript Type |
Minireviews |
Article Title |
Beyond the gluten-free diet: Innovations in celiac disease therapeutics
|
Manuscript Source |
Invited Manuscript |
All Author List |
Sara Massironi, Marianna Franchina, Alessandra Elvevi and Donatella Barisani |
Funding Agency and Grant Number |
|
Corresponding Author |
Sara Massironi, MD, PhD, Adjunct Professor, Division of Gastroenterology, Fondazione IRCCS San Gerardo dei Tintori, University of Milano-Bicocca, Via Pergolesi 33, Monza 20900, Italy. sara.massironi@libero.it |
Key Words |
Celiac disease; Gluten tolerance; Enzymatic degradation; Therapeutic advances; Transglutaminase inhibitors; Tight junction modulators |
Core Tip |
The landscape of celiac disease treatment is evolving beyond the traditional gluten-free diet due to the challenges of strict adherence to the diet and incomplete resolution of symptoms. This review highlights emerging therapeutic strategies, including gluten sequestration and degradation, gluten tolerance induction, tight junction modulators, transglutaminase inhibitors, lymphocyte trafficking and homing inhibitors. These novel therapies, which target specific molecular and immune signaling pathways, promise to improve patient outcomes and quality of life by reducing dietary restrictions and addressing persistent inflammation and symptoms. Further research and multidisciplinary collaboration are critical to integrate these advances into standard clinical practice. |
Publish Date |
2024-09-29 09:24 |
Citation |
<p>Massironi S, Franchina M, Elvevi A, Barisani D. Beyond the gluten-free diet: Innovations in celiac disease therapeutics. <i>World J Gastroenterol</i> 2024; 30(38): 4194-4210</p> |
URL |
https://www.wjgnet.com/1007-9327/full/v30/i38/4194.htm |
DOI |
https://dx.doi.org/10.3748/wjg.v30.i38.4194 |
© 2004-2024 Baishideng Publishing Group Inc. All rights reserved. 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA
California Corporate Number: 3537345